Details of the Probe-central Interaction Altas
General Information of Experiment
| Probe Name | FBPP2 | Probe Info | ||||
|---|---|---|---|---|---|---|
| Probe concentration | 10 uM | |||||
| Criteria | Quantification: Probe vs (Probe+Competitor) | |||||
| Quantitative Method |
LFQ
|
|||||
| Competitor Name | Tranylcypromine | Competitor Info | ||||
| Competitor Concentration | 100 uM | |||||
| In Vivo Experiment Model | Model Type |
|
Living cell | |||
| Derived Tissue |
|
Adrenal | ||||
| Disease Model | Bone marrow neuroblastoma [ICD11: 2A00] | |||||
| Model Name | Human neuroblastoma cells (SH-SY5Y) | |||||
Interaction Altas of This Experiment [1]
Enzyme
| Target ID | Target Name | Binding Ratio | ||||
|---|---|---|---|---|---|---|
| LDTP10884 | Sialidase-1 (NEU1) | 13.0 | ||||
| LDTP11215 | Plasma alpha-L-fucosidase (FUCA2) | 9.0 | ||||
| LDTP11059 | ADP-ribose glycohydrolase MACROD1 (MACROD1) | 8.4 | ||||
| LDTP00338 | Lysosomal alpha-mannosidase (MAN2B1) | 7.6 | ||||
| LDTP14801 | Di-N-acetylchitobiase (CTBS) | 7.3 | ||||
| LDTP02217 | Procathepsin L (CTSL) | 7.1 | ||||
| LDTP02799 | N-acetylglucosamine-6-sulfatase (GNS) | 6.7 | ||||
| LDTP02366 | Pro-cathepsin H (CTSH) | 5.7 | ||||
| LDTP09256 | Putative phospholipase B-like 2 (PLBD2) | 5.5 | ||||
| LDTP16032 | Retinoid-inducible serine carboxypeptidase (SCPEP1) | 5.3 | ||||
| LDTP12135 | Sialate O-acetylesterase (SIAE) | 4.2 | ||||
| LDTP04388 | Palmitoyl-protein thioesterase 1 (PPT1) | 4.1 | ||||
| LDTP02141 | Alpha-galactosidase A (GLA) | 4.0 | ||||
| LDTP13172 | Cathepsin F (CTSF) | 3.9 | ||||
| LDTP15988 | Probable serine carboxypeptidase CPVL (CPVL) | 3.7 | ||||
| LDTP00316 | Ribonuclease T2 (RNASET2) | 3.6 | ||||
| LDTP04004 | Lysosomal Pro-X carboxypeptidase (PRCP) | 3.6 | ||||
| LDTP03748 | Alpha-L-iduronidase (IDUA) | 3.5 | ||||
| LDTP02223 | Cathepsin B (CTSB) | 3.4 | ||||
| LDTP13294 | Dipeptidyl peptidase 2 (DPP7) | 3.3 | ||||
| LDTP10888 | Legumain (LGMN) | 3.3 | ||||
| LDTP02216 | Beta-hexosaminidase subunit beta (HEXB) | 3.0 | ||||
| LDTP02169 | Beta-hexosaminidase subunit alpha (HEXA) | 3.0 | ||||
| LDTP00428 | Tripeptidyl-peptidase 1 (TPP1) | 2.8 | ||||
| LDTP09088 | Phospholipase A2 group XV (PLA2G15) | 2.8 | ||||
| LDTP02006 | Tissue alpha-L-fucosidase (FUCA1) | 2.8 | ||||
| LDTP02005 | Lysosomal acid glucosylceramidase (GBA1) | 2.5 | ||||
| LDTP02883 | Alpha-N-acetylgalactosaminidase (NAGA) | 2.4 | ||||
| LDTP00185 | Deoxyribonuclease-2-alpha (DNASE2) | 2.3 | ||||
| LDTP09886 | Gamma-glutamyl hydrolase (GGH) | 2.3 | ||||
| LDTP04572 | Dipeptidyl peptidase 1 (CTSC) | 2.2 | ||||
| LDTP02865 | Carboxypeptidase E (CPE) | 2.2 | ||||
| LDTP00282 | Beta-mannosidase (MANBA) | 2.1 | ||||
| LDTP02807 | Arylsulfatase B (ARSB) | 2.1 | ||||
| LDTP04634 | Alpha-N-acetylglucosaminidase (NAGLU) | 2.1 | ||||
| LDTP04255 | Transmembrane ascorbate-dependent reductase CYB561 (CYB561) | 2.0 | ||||
| LDTP02539 | Lysosomal acid phosphatase (ACP2) | 2.0 | ||||
Transporter and channel
| Target ID | Target Name | Binding Ratio | ||||
|---|---|---|---|---|---|---|
| LDTP12042 | Proton-activated chloride channel (PACC1) | 5.4 | ||||
| LDTP12874 | ADP-ribosylation factor-binding protein GGA3 (GGA3) | 4.9 | ||||
| LDTP12981 | Proton-transporting V-type ATPase complex assembly regulator TMEM9 (TMEM9) | 4.3 | ||||
| LDTP17246 | Sodium-dependent glucose transporter 1 (MFSD4B) | 3.7 | ||||
| LDTP08327 | Osteopetrosis-associated transmembrane protein 1 (OSTM1) | 3.5 | ||||
| LDTP06945 | Sigma intracellular receptor 2 (TMEM97) | 2.9 | ||||
| LDTP02266 | Synaptophysin (SYP) | 2.8 | ||||
| LDTP03061 | Cation-dependent mannose-6-phosphate receptor (M6PR) | 2.7 | ||||
| LDTP10885 | Sortilin (SORT1) | 2.4 | ||||
| LDTP04459 | H(+)/Cl(-) exchange transporter 3 (CLCN3) | 2.4 | ||||
| LDTP02562 | Lysosome-associated membrane glycoprotein 1 (LAMP1) | 2.2 | ||||
Cytokine and receptor
| Target ID | Target Name | Binding Ratio | ||||
|---|---|---|---|---|---|---|
| LDTP03377 | Ciliary neurotrophic factor receptor subunit alpha (CNTFR) | 2.1 | ||||
Other
| Target ID | Target Name | Binding Ratio | ||||
|---|---|---|---|---|---|---|
| LDTP04172 | Tissue factor pathway inhibitor 2 (TFPI2) | 4.5 | ||||
| LDTP03773 | Metalloproteinase inhibitor 3 (TIMP3) | 3.2 | ||||
| LDTP02937 | Insulin-like growth factor-binding protein 2 (IGFBP2) | 3.0 | ||||
| LDTP13281 | ProSAAS (PCSK1N) | 2.9 | ||||
| LDTP03175 | Galanin peptides (GAL) | 2.8 | ||||
| LDTP02927 | Ganglioside GM2 activator (GM2A) | 2.8 | ||||
| LDTP02715 | CD99 antigen (CD99) | 2.7 | ||||
| LDTP00779 | Trans-Golgi network integral membrane protein 2 (TGOLN2) | 2.6 | ||||
| LDTP11461 | Seizure 6-like protein (SEZ6L) | 2.5 | ||||
| LDTP10889 | Perilipin-2 (PLIN2) | 2.5 | ||||
| LDTP04650 | Microfibrillar-associated protein 2 (MFAP2) | 2.3 | ||||
| LDTP07703 | Seizure 6-like protein 2 (SEZ6L2) | 2.1 | ||||
